VanEck Associates’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Buy
98,802
+3,026
+3% +$149K ﹤0.01% 832
2026
Q1
$4.52M Buy
95,776
+50,559
+112% +$2.51M ﹤0.01% 839
2025
Q4
$2.13M Buy
45,217
+6,468
+17% +$300K ﹤0.01% 984
2025
Q3
$1.63M Buy
38,749
+3,782
+11% +$152K ﹤0.01% 1018
2025
Q2
$1.28M Buy
34,967
+4,966
+17% +$165K ﹤0.01% 1019
2025
Q1
$909K Buy
30,001
+1,201
+4% +$34.6K ﹤0.01% 1053
2024
Q4
$818K Buy
28,800
+14,652
+104% +$394K ﹤0.01% 1067
2024
Q3
$363K Buy
+14,148
New +$276K ﹤0.01% 1123

Other funds holding AHR

VanEck Associates's AHR Position: Q2 2026 in Review

VanEck Associates increased its American Healthcare REIT (AHR) stake by 3.2% in Q2 2026, buying an estimated $149K and bringing the position to 98,802 shares worth $5.15M. The position accounts for ﹤0.01% of the portfolio, ranked #832.

VanEck Associates first reported a position in AHR in Q3 2024 and has held it in 8 quarters since. 571 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • VanEck Associates held 98,802 shares of American Healthcare REIT worth $5.15M as of Q2 2026.
  • VanEck Associates bought 3,026 American Healthcare REIT shares in Q2 2026, an estimated $149K.
  • American Healthcare REIT made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #832 holding.
  • VanEck Associates first reported a position in American Healthcare REIT in Q3 2024 and has held it in 8 quarters since.
  • 571 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.